acute myelogenous leukemia

Showing NaN - NaN of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +3 more
  • total body irradiation
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 17, 2021

Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

Terminated
  • Acute Myelogenous Leukemia
  • Birmingham, Alabama
  • +16 more
Apr 14, 2021

Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • MCLA-117 bispecific antibody
  • Augusta, Georgia
  • +9 more
May 6, 2021

Acute Myelogenous Leukemia Trial in United States (KIR genotype)

Completed
  • Acute Myelogenous Leukemia
  • KIR genotype
  • Scottsdale, Arizona
  • +18 more
Mar 9, 2021

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive

Completed
  • Acute Myeloid Leukemia
  • Acute Myelogenous Leukemia
  • Tucson, Arizona
  • +29 more
Jun 17, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

Terminated
  • Acute Myelogenous Leukemia
  • +4 more
  • CliniMACS® CD34 Reagent System
  • +5 more
  • New York, New York
    Weill Cornell Medical College
Jun 12, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (micafungin, posaconazole)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 4, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (CPX-351)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • New York, New York
    Weill Cornell Medical College
Jan 12, 2018

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma Trial in United States (Food Safety Guidelines,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Food Safety Guidelines
  • Neutropenic Diet
  • San Diego, California
  • +5 more
Feb 7, 2017

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 16, 2016

Acute Myelogenous Leukemia Trial in Buffalo, New York, Philadelphia (KX2-391)

Completed
  • Acute Myelogenous Leukemia
  • Buffalo, New York
  • +2 more
Dec 4, 2015

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)

Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +7 more
Jun 4, 2015

Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)

Completed
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • Phoenix, Arizona
  • +19 more
Mar 17, 2014

Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • clofarabine (IV formulation)
  • +2 more
  • Scottsdale, Arizona
  • +56 more
Mar 17, 2014

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Birmingham, Alabama
  • +12 more
Mar 17, 2014